Icure Pharmaceutical Incorporation

KOSDAQ:A175250 Stock Report

Market Cap: ₩73.3b

Icure Pharmaceutical Incorporation Dividends and Buybacks

Dividend criteria checks 0/6

Icure Pharmaceutical Incorporation does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-46.0%

Buyback Yield

Total Shareholder Yield-46.0%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Icure Pharmaceutical Incorporation (KOSDAQ:175250) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Sep 04
Icure Pharmaceutical Incorporation (KOSDAQ:175250) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Is Icure Pharmaceutical Incorporation (KOSDAQ:175250) A Risky Investment?

Aug 28
Is Icure Pharmaceutical Incorporation (KOSDAQ:175250) A Risky Investment?

What Icure Pharmaceutical Incorporation's (KOSDAQ:175250) 27% Share Price Gain Is Not Telling You

Jul 21
What Icure Pharmaceutical Incorporation's (KOSDAQ:175250) 27% Share Price Gain Is Not Telling You

Icure Pharmaceutical Incorporation (KOSDAQ:175250) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

May 31
Icure Pharmaceutical Incorporation (KOSDAQ:175250) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Is Icure Pharmaceutical Incorporation (KOSDAQ:175250) Using Debt In A Risky Way?

May 27
Is Icure Pharmaceutical Incorporation (KOSDAQ:175250) Using Debt In A Risky Way?

Some Shareholders Feeling Restless Over Icure Pharmaceutical Incorporation's (KOSDAQ:175250) P/S Ratio

Mar 07
Some Shareholders Feeling Restless Over Icure Pharmaceutical Incorporation's (KOSDAQ:175250) P/S Ratio

We Think Icure Pharmaceutical Incorporation (KOSDAQ:175250) Has A Fair Chunk Of Debt

Dec 25
We Think Icure Pharmaceutical Incorporation (KOSDAQ:175250) Has A Fair Chunk Of Debt

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if A175250's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A175250's dividend payments have been increasing.


Dividend Yield vs Market

Icure Pharmaceutical Incorporation Dividend Yield vs Market
How does A175250 dividend yield compare to the market?
SegmentDividend Yield
Company (A175250)n/a
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)3.9%
Industry Average (Personal Products)1.1%
Analyst forecast (A175250) (up to 3 years)n/a

Notable Dividend: Unable to evaluate A175250's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A175250's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate A175250's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A175250 has not reported any payouts.


Discover strong dividend paying companies